Clinical Trials on Human Immunodeficiency Viruses in Canada

Total 1417 results

University Health Network, Toronto

Terminated

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Chronic Hepatitis C - Genotype 3

Canada
GlaxoSmithKline

Completed

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Influenza

United States, Canada
GlaxoSmithKline

Completed

Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

Hepatitis | Acute Hepatitis A

Panama
CSL Behring

Completed

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

Primary Immune Deficiency | Secondary Immune Deficiency

Canada
University Health Network, Toronto
Hoffmann-La Roche

Terminated

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

HIV Infections | Chronic Hepatitis C

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Influenza

United States, Canada
Hoffmann-La Roche

Completed

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Influenza

United States, Denmark, Canada
University Health Network, Toronto
Gilead Sciences

Completed

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic | Cirrhosis, Decompensated

Canada
University Health Network, Toronto

Unknown

Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy

Hepatitis B | Hepatitis C

Canada
University of British Columbia
PHAC/CIHR Influenza Research Network

Completed

Comparison of 4 Influenza Vaccines in Seniors (PCIRNRT09)

Influenza Vaccine

Canada
University of Manitoba
Roche Pharma AG

Completed

Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity (Praire)

Chronic Hepatitis C

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

Influenza

United States, Canada
Ottawa Hospital Research Institute

Recruiting

A Healthy People Initiative: Building the Socio-Economic Capital of Low Income Population At-Risk for HIV and Hepatitis-C

Substance Use Disorders | Nicotine Dependence

Canada
Medicago

Completed

Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

United States, Canada
Antios Therapeutics, Inc

Completed

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Canada, Moldova, Republic of, Ukraine
Octapharma

Completed

Non-Interventional Study on the Tolerability and Efficacy of IVIG (GAM 10-06)

Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG

Canada, Austria, France, Spain, United Kingdom
Dalhousie University
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR); Public Health...

Completed

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults (SOS-VE01)

Influenza

Canada
Bristol-Myers Squibb

Completed

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Chronic Hepatitis C

United States, Canada
GlaxoSmithKline

Completed

This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama

Hepatitis A Vaccine

Panama
BioWest Therapeutics Inc

Unknown

A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Chronic Hepatitis C

Canada
Trial Management Group Inc.
Hoffmann-La Roche

Completed

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza (FOCUS)

Influenza

Canada
Medicago

Completed

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Influenza | Respiratory Tract Disease

Canada
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Anti-HIV Medications for People Recently Infected With HIV

HIV Infections

United States, Canada
Fundación Pública Andaluza Progreso y Salud

Completed

Register of Telaprevir and Boceprevir in Routine Clinical Practice

Hepatitis C

Spain
Kenneth Rockwood
Nova Scotia Health Authority; Research Nova Scotia; Department of Health, Nova...

Enrolling by invitation

Far-UVC Light Devices in Long-term Care Facilities to Reduce Infections (UVCinLTCs)

COVID-19 Respiratory Infection | Influenza -Like Illness | Respiratory Virus Infection

Canada
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Hepatitis C Virus Infection

Canada
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age

Influenza

Canada, Honduras, Dominican Republic
Janssen Research & Development, LLC

Terminated

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Hepatitis C

Singapore, Canada, Poland, New Zealand
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age

Influenza

United States, Canada
Hoffmann-La Roche

Completed

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

HIV Infections

Canada, United States, Puerto Rico
McGill University Health Centre/Research Institute...
Merck Sharp & Dohme LLC; CIHR Canadian HIV Trials Network

Completed

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Hepatitis C | HIV | Liver Fibrosis

Canada
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals

Withdrawn

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Hepatitis B Virus

United States, Thailand, Canada, Brazil
Ottawa Hospital Research Institute
Ontario HIV Treatment Network; Public Health Agency of Canada (PHAC); CIHR Canadian...

Completed

Influenza Vaccine in HIV

HIV | Influenza

Canada
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

Influenza

United States, Canada
GlaxoSmithKline

Terminated

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

Haemophilus Influenzae | Streptococcus Pneumoniae

Canada
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Hepatitis B | Hepatitis B, Chronic | HBV

Canada, United Kingdom
Vertex Pharmaceuticals Incorporated
ViroChem Pharma

Completed

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Hepatitis C, Chronic

Canada
Triangle Pharmaceuticals

Unknown

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis B

United States, Canada, China, France, Singapore
GlaxoSmithKline

Completed

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Influenza

United States, Canada
Université de Sherbrooke

Unknown

Effect of Nasal Continuous Positive Airway Pressure (CPAP) on Oral Feeding in Human Neonates

Oral Feeding in Human Neonates During Nasal CPAP

Canada
University of California, Los Angeles
Patient-Centered Outcomes Research Institute

Enrolling by invitation

Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

Human Papillomavirus Infection

United States
Novartis
Novartis Pharmaceuticals

Completed

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

Hepatitis B

Canada, France, United States, China
Vertex Pharmaceuticals Incorporated
Duke Clinical Research Institute; ViroChem Pharma

Completed

Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection

HCV Infection

Puerto Rico, United States, Canada
Beckman Coulter, Inc.

Terminated

Clinical Performance Evaluation of DxN HBV Assay

Hepatitis B

United States, Canada
Pfizer

Completed

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

HIV Infection | Hepatitis C

Canada, United States
Janssen Research & Development, LLC

Completed

A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease

Respiratory Syncytial Viruses

Taiwan, Belgium, United Kingdom, Argentina, Panama
National Institute of Allergy and Infectious Diseases...
National Center for Advancing Translational Sciences (NCATS); Office of Rare... and other collaborators

Enrolling by invitation

Natural History Study of SCID Disorders

Omenn Syndrome | Reticular Dysgenesis | Severe Combined Immunodeficiency (SCID) | XSCID | Leaky SCID | ADA SCID

United States, Canada
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre...

Completed

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound (ELF)

Hepatitis B | Hepatitis C | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)

Canada
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Hepatitis B Research Network Pediatric Cohort Study (HBRN)

Hepatitis B

United States, Canada
National Institute of Diabetes and Digestive and...

Completed

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B

United States, Canada

Clinical Trials on Human Immunodeficiency Viruses in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations